... San Antonio Breast Cancer Symposium (SABCS 2025) being held December 9 ... NiKang Therapeutics is a clinical-stage biotech company focused on ...
News
- NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly ... - Rutland Herald
- Wobble Genomics To Present New Data At SABCS Confirming Platform's Ability To ... - Morningstar
EDINBURGH, Scotland, Dec. 11, 2025 /PRNewswire/ -- Wobble Genomics, a biotechnology ... San Antonio, Texas. The data demonstrates the ability to ...
- Roche's Oral SERD Cuts Death Risk by 30% in Early-Stage Breast Cancer - BioSpace
Roche presented these findings at the 2025 San Antonio Breast Cancer Symposium (SABCS). ... biotech and science. He can be reached at tristan ...
- Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase ... - StreetInsider
The additional study results were presented in an oral presentation session at the 2025 San Antonio Breast Cancer Symposium (“SABCS”) today, Thursday, ...
- ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial
SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan ... Biotechnology. Lathrop had no relevant financial disclosures ...